{"id":"W2887131751","doi":"10.18632/oncotarget.25739","title":"Dual targeting of HER2-positive breast cancer with trastuzumab emtansine and pertuzumab: understanding clinical trial results","year":2018,"lang":"en","type":"review","venue":"Oncotarget","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Pertuzumab; Trastuzumab; Trastuzumab emtansine; Medicine; Oncology; Breast cancer; Internal medicine; Cancer; Clinical trial","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.03066421,0.0008846447,0.003364479,0.0005424258,0.000235407,0.003825501,0.001302397,0.002055976,0.003418496],"category_scores_gemma":[0.02818106,0.0003558986,0.002313731,0.0009972511,0.0008600058,0.003344455,0.0009977977,0.004113637,0.0007679811],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001177053,"about_ca_system_score_gemma":0.001390278,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002134412,"about_ca_topic_score_gemma":0.0005306246,"domain_scores_codex":[0.9926772,0.005156339,0.0006443547,0.0004182895,0.000671446,0.0004324128],"domain_scores_gemma":[0.975871,0.01691283,0.003653866,0.001065245,0.001594795,0.0009022172],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.1196041,0.002305587,0.01533612,0.0177567,0.008623984,0.0002819981,0.0008408284,0.005056362,0.005589439,0.01111431,0.02579232,0.7876982],"study_design_scores_gemma":[0.1402655,0.1366038,0.06905984,0.03200751,0.04111391,0.001829355,0.001465666,0.0308172,0.008013792,0.08757247,0.4507841,0.0004669184],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.1659221,0.7512405,0.008350033,0.05228774,0.002317843,0.002396438,0.002053285,0.0001971202,0.01523496],"genre_scores_gemma":[0.7418688,0.1939885,0.01051493,0.03590444,0.005151129,0.004534068,0.003322145,0.0001781709,0.004537803],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.03066421,"threshold_uncertainty_score":0.1621698,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2599617239256731,"score_gpt":0.4952517428112211,"score_spread":0.235290018885548,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}